This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

18 Oct 2012

Thermogelled capsules made from excipient Hypromellose perform in study

The production of HPMC capsules using a proprietary thermal gelling process rather than a gelling agent could reduce the risk of delayed drug release.


A new study has shown that plant-based capsules made from an excipient called Hypromellose (HPMC) have a faster and more predictable dissolution profile when manufactured using a thermal gelling process rather than with gelling agents.

Related News